Ирина Мещерякова/iStock Editorial via Getty Images Recently, a bunch of negative catalysts have been pummeling the shares of Apple Inc. (NASDAQ:AAPL), with Apple shares declining by 11% YTD while the S&P 500 Index (SP500) has rallied by 10% (Figure 1). Figure 1 – Apple has declined by 11% while the S&P 500 has rallied by…
manassanant pamai When looking at my personal portfolio it consists of different asset classes – real estate, stocks, and gold (to clarify, real estate is only the house I am living in as I don’t assume real estate being a good investment). And although I have covered gold from time to time, I mostly focus…
In a new blog post, Vitalik Buterin noted the loss of the original web3 values, the ways that the community can get back on track, and the progress that Ethereum has made so far. Vitalik Buterin has always been a big personality. As one of the founders of Ethereum, he has been a major figure…
DNY59 Pfizer Inc. (NYSE:PFE) has been one of the most frustrating companies in my coverage, as my previous bullish thesis on the leading biopharma leader hasn’t panned out. The company’s outlook on its COVID franchise has proved to be more challenging than anticipated, leading to over-optimistic Wall Street estimates. As a result, I believe the…
SlavkoSereda/iStock via Getty Images My bullish thesis on Sociedad Quimica y Minera de Chile S.A. (NYSE:SQM) hasn’t worked out over the past six to seven months as the oversupply dynamics in the lithium market were more pronounced than I had anticipated. The lessons learned include placing too much emphasis on SQM’s best-in-class “A+” valuation grade…
Prostock-Studio Investment thesis Medifast’s (NYSE:MED) stock hit an all-time high in late May 2021 because the company has been delivering stellar financial performance. But in June 2021, the FDA started approving weight-loss drugs, a big disruption to Medifast. Since then, the stock price declined by more than four times, and the forward dividend yield is…
bunnylady/E+ via Getty Images iShares Residential and Multisector Real Estate ETF (NYSEARCA:REZ) is an interesting REIT fund. This is one of those funds I wouldn’t recommend for most investors because of its shift in focus, its sporadic distribution history, high expense rate and easy replicability. Originally this fund was meant to include REITs that focus…
bymuratdeniz Introduction Sage Therapeutics (NASDAQ:SAGE) is a biopharmaceutical company with a specialization in brain health medications. They focus on treating disorders such as depression, neurology, and neuropsychiatry by targeting the central nervous system’s GABA and NMDA receptor systems. With products like Zulresso (intravenous brexanolone) for postpartum depression, Sage continues to advance in the field by…
Analysts expect that the Vision Fund investment arm of SoftBank Group turned a profit and might announce as much in its upcoming report. SoftBank Group’s Vision Fund may finally turn a profit after multiple losses due to the current boom surrounding artificial intelligence (AI). After five quarters where the Japanese giant recorded losses, Vision Fund’s…
This is an opinion editorial by Bitcoin Graffiti, a software developer and graffiti artist. Source “Those things which I am saying now may be obscure, yet they will be made clearer in their proper place.” –Nicolaus Copernicus In the annals of history, Nicholas Copernicus is celebrated as the groundbreaking astronomer who toppled the geocentric view…